IRCT20231017059748N3招募中3 期
Evaluation of the Effects of Baricitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Randomized Clinical Trial
Vice chancellor for Research,Tabriz University Of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Adults with mild to moderate Acute Respiratory Distress Syndrome (ARDS) who require oxygen therapy (PaO2/FiO2 < 300 mmHg)
- •Patients who are capable of long-term supine position
排除标准
- •Age below 18 and above 80 years
- •concomitant diseases (infection/suppression of immune system, human immunodeficiency virus, liver, kidney and/acquired immunodeficiency syndrome)
研究者
相似试验
招募中
3 期
Evaluation of therapeutic effect of baricitinib in patients with severe pneumonia requiring non-invasive ventilation induced to Covid 19Acute viral infection caused by the corona virus (COVID-19).COVID-19, virus identifiedU07.1IRCT20220508054780N1Mashhad University of Medical Sciences15
招募中
不适用
Analysis of the efficacy of baricitinib in bone erosion assessed by HR-pQCT in rheumatoid arthritis.rheumatoid arthritisJPRN-UMIN000033150agasaki University Graduate School of Biomedical Sciences42
招募中
3 期
Baricitinib in patients with relapsing or naïve dermatomyositis (BIRD)2024-511899-32-00Assistance Publique Hopitaux De Paris62
尚未招募
3 期
studing the therapeutic effect of baricitinib and its side effects in LPP (Lichen Plano Pilaris)lichen planopilaris.Chapter XII Diseases of the skin and subcutaneous tissue(L00-L99)IRCT20221101056374N1Tehran University of Medical Sciences22
未知
2 期
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)-I4V-MC-JAHHJPRN-jRCT2080223304Eli Lilly Japan K.K.